Sp3 is a bifunctional transcription factor that has been reported to stimulate or repress the transcription of numerous genes. Although the size of Sp3 mRNA is 4.0 kb, the size of the known Sp3 cDNA sequence is 3.6 kb. Thus, Sp3 functional studies have been performed with an artificially introduced start codon, and thus an aminoterminus that differs from the wild-type. Ideally, fulllength cDNA expression vectors with the appropriate start codon should be utilized for these studies. Using 5'rapid amplification of cDNA ends, a full-length Sp3 cDNA clone was generated and the sequence verified in nine cell lines. No AUG initiation codon was present. However, stop codons were present in all three frames 5' to the known coding sequence. In vitro translation of this full-length cDNA clone produced the expected three isoforms-one at 100 kDa and two in the mid 60 kDa range. Electrophoretic mobility shift assays showed that the protein products had the ability to bind to the Sp1/3 consensus sequence. In vitro studies, using our Sp3 clone and site directed mutagenesis, identified the translation initiation site for the larger isoform as AUA. AUA has not been previously described as an endogenous initiation codon in eukaryotes.
Introduction
Sp3, a bifunctional member of the Sp1 family of transcription factors (Majello et al., 1997) was originally cloned in 1992 by two different groups (Hagen et al., 1992; Kingsley and Winoto, 1992) . Sp3 is expressed in most tissues and participates in the regulation of many genes. These include the dopamine receptor D(1A) , nicotinic beta 4 subunit (Melnikova et al., 2000) , and the potassium channel (Redell and Temple, 1998) . It also participates in the regulation of IL-10 (Tone et al., 2000) and in signaling genes, such as calmodulin (Pan et al., 2000) . Due to its involvement in the regulation of multiple genes in many tissues, cells must have tightly controlled mechanisms to regulate Sp3 levels and activity.
As with the rest of the members in the Sp1 family, Sp3 contains three zinc fingers near the C-terminus. It also has two glutamine-rich activation domains near its N-terminus (Suske, 1999) . Sp3, as well as Sp1 and Sp4, recognize the GC box (GGGGCGGGG) with the greatest efficiency, although it can also bind the GT box (GGTGTGGGG) (Hagen et al., 1992) . Western blots have previously shown that there are three isoforms of Sp3-one at 120 kDa and two in the mid-80 kDa range (Gao and Tsebg, 1996) , although in vitro translation of Sp3 cDNA produces an isoform at 100 kDa and two in the mid-60 kDa range (Kingsley and Winoto, 1992) . This disparity in size is most likely due to glycosylation of the naturally occurring isoforms since Sp1 is known to be glycosylated (Du et al., 2000) . Also, the in vitro translation in rabbit reticulocyte lysate does not produce glycosylated proteins unless microsomal membranes are added (Walter and Blobel, 1983; Tymms, 1995) . Even though there are three translated isoforms, there is only one mRNA that is detectable by Northern blot (Hagen et al., 1992; Kingsley and Winoto, 1992) .
Sp3 has both stimulatory and inhibitory transcriptional activity (Majello et al., 1997) . Since Sp3 has three isoforms (Kingsley and Winoto, 1992) and two different activities, one theory explaining the bifunctional activity of Sp3 is that the isoforms have differing capacities at transcriptional activation. One hypothesis is that the smaller isoforms act as repressors, while the full-length isoform acts as an activator (Kennett et al., 1997) . This is supported by a study of the rat calmodulin (CaM I) gene promoter, in which the large isoform of Sp3 stimulates CaM I expression, while the small isoforms repress gene transcription (Pan et al., 2000) . If the ratios between the *To whom correspondence should be addressed. Tel: 1-202-687-1513; Fax: 1-202-687-1800 E-mail: richertj@georgetown.edu Sp3 isoforms determine Sp3 activity, it is likely that the cells would have mechanisms to tightly regulate the translation of each isoform.
Since studies examining Sp3's bifunctional activity have been performed with an artificial start codon or an incomplete transcript and therefore an N-terminal end for the large isoform that differs from the wild-type, it is premature to assign an inhibitory/enhancer function to a single amino acid, or to reach a conclusion about the potential role of isoform ratios in the regulation of Sp3's bifunctional activity. Fulllength cDNA expression vectors with the appropriate start codon are necessary before the function can be fully assessed.
In this paper, we used 5' rapid amplification of complementary DNA ends (5'RACE) to obtain the 5' end of the Sp3 gene. We verified the sequence in 9 different cell lines by reverse transcriptase polymerase chain reaction (RT-PCR). We have also shown by Northern blot that radiolabeled probes that are specific for either the newly obtained 5' sequence, or the previously published Sp3 sequence, hybridize to mRNA of the same size. Our sequence analysis of the newly obtained 5' sequence for Sp3 showed stop codons in all three reading frames that were situated 5' to the known open-reading frame, yet no AUG initiation codon was present. We then created a full-length expression construct for Sp3 and translated all three isoforms in vitro. Next, we demonstrated that all three isoforms bind to the GC box (Sp1/3 consensus sequence), and are recognized by the anti-Sp3 antibody using an electrophoretic mobility shift assay. Using site-directed mutagenesis to create a number of change-of-frame, gain-offunction, and loss-of-function mutations, the translation initiation site for the larger (100 kDa) isoform was identified as AUA.
Materials and Methods
Rapid amplification of cDNA ends and plasmid construction Template mRNA was isolated from MDA-MB-231 cells using the quick prep mRNA purification method (Amersham Pharmacia Biotech, Piscataway, USA). 5'RACE was performed using the 5'RACE method v.2.0 (Invitrogen Life Technologies, Carlsbad, USA), which used the GC rich protocol and primers that are listed in Table 1 . All of the nested PCR reactions were performed with Taq polymerase (Invitrogen) in the presence of 10% DMSO. PCR amplified bands were cloned into the PCRII vector using the TA Cloning kit (Invitrogen). The resulting clones were sequenced using the dRhodamine dye terminator sequencing method (Applied Biosystems, Foster City, USA). Sequences were aligned with the Sp3 sequence using the BLAST engine that is located on the National Center for Biotechnology Information webpage at http://www3.ncbi.nlm.nih. gov/. Verification of the sequence was performed on mRNA that was isolated from MDA-MB-231, MCF7, SW13, TSU, and ME180 cells using the quick prep mRNA purification method (Amersham). Total RNA was isolated with TriReagent (Molecular Research Center, Inc., Cincinnati, USA) from four EBV-transformed human B cell lines. The cDNA synthesis was carried out using Thermoscript and random hexamers (Invitrogen). PCR was performed with High Fidelity Platinum Taq (Invitrogen) in the presence of 10% DMSO. PCR of basepairs 9-1069 was performed on mRNA from MDA-MB-231 and MCF7 cell lines with the F2 and R1 primers (Table 1) . PCR of basepairs 299 to 710 was performed on mRNA that was isolated from SW13, TSU, and ME180 cell lines. RNA was isolated from the four EBV transformed B cell lines using primers F4 and R2 (Table 1) . PCR amplified bands were cloned and sequenced. 3'RACE was performed using the Sp3-3R3 primer (Table 1 ) and the Marathon Ready cDNA method from human lymphocytes (Clontech Laboratories, Inc., Palo Alto, USA). The amplified fragments were cloned and sequenced. A full expression construct was obtained by ligating the Mun I and Xho I digestion products of the bp 9-1069 PCR product with the 3'RACE PCR product.
Site directed mutagenesis and in vitro translation All of the mutations were produced with the Quick Change Site Directed Mutagenesis Method (Stratagene, La Jolla, USA) in the presence of 5% DMSO. For coupled in vitro translation, the Sp6 T N T coupled rabbit reticulocyte lysate method (Promega Corporation, Madison, USA) was utilized. Aliquots of 500 ng of DNA were used in 25 µl reactions in the presence of [ 35 S]methionine (1 µl of 10 µCi/µl). Each reaction (10 µl) was resolved by 7.5% or 9% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The gels were then fixed in 7% acetic acid, 7% methanol, and 1% glycerol for 10 min. The gels were dried at 80 o C under vacuum for 1 h and autoradiographed for 3 to 10 days.
Electrophoretic mobility shift assay The Sp1 consensus sequence oligonucleotide was obtained from Promega. The oligonucleotide was end labeled with polynucleotide kinase (PNK) (Invitrogen). The 1X buffer for the binding reaction was 88 mM KCl, 10 mM HEPES pH 7.9, 12% glycerol, and 10 mM Tris-HCl, pH 8.0. The binding reaction was set up by adding 6 µl of 5x buffer, 0.3 µl 0.1 M DTT, and 0.5 µg E. coli DNA, and 10 µl of RRL with or without Sp3, as required. Water was added so that the final volume was 30 µl. The reaction was allowed to sit at room temperature for 20 min. Next, 1 µl of either α-Sp3 antibody (generously provided by Dr. Jonathan Horowitz at Duke University), unlabeled TFIID consensus sequence oligonucleotide (Promega), or unlabeled Sp1 consensus sequence oligonucleotide (Promega) was added as needed. The reaction was allowed to incubate at room temperature for 20 min. Next, 10,000 DPM of labeled Sp1 consensus oligonucleotide was added. The reaction was incubated at room temperature for 20 min. The samples were resolved on a 24 cm, 6% polyacrylamide gel. The gel was dried for 1 h at 80 o C under vacuum and autoradiographed for 3 days. Probes were created by PCR of the F3-H8 fragment, or the IP F 17-IP R 18 fragment (Grekova, et al., 1996) (shown in Figs. 1 and  3 ). Probes were labeled using the Random Primers DNA labeling Table 1 . A List of PCR primers and sequences. In the first column are listed the names of the primers used for 5'RACE, sequence verification, 3'RACE and site directed mutagenesis. In the second column are listed the positions of the primers or mutations. In the third column are listed the sequences of the primers.
Primer name
Position Sequence 
Results
Obtaining the 5' cDNA sequence of Sp3 The known cDNA sequence of Sp3 is 3.6 kb including the poly A tail, while the size of Sp3 mRNA is 4.2 kb by Northern blot (Kingsley and Winoto, 1992) . Our own investigations, however, have determined the size to be closer to 4 kb, consistently running at the bottom edge of the 28S rRNA band (Fig. 1) . To obtain the 5' end of the mRNA sequence, 5'RACE was performed on mRNA that was isolated from MDA-MB-231 cells (mammary gland adenocarcinoma). A number of clones were obtained, and their sequences compared with the published sequence for Sp3 (accession # M97191). Clones, which contained sequences that overlapped with the published sequence for Sp3 and new 5' data, were used to extend the known 5' end of the Sp3 cDNA ( Fig. 2A) , and a full cDNA sequence was obtained (accession On the left is the autoradiograph after hybridization. On the far right are listed the sizes of the RNA ladder. At the bottom is a map that shows to which regions the probe hybridized. The dotted line represents the sequence that was obtained by 5'RACE. The solid line represents the previously published sequence.
Fig. 2. 5' rapid amplification of cDNA ends (RACE). (A)
5'RACE was used to extend the known sequence of Sp3 cDNA to the 5' end using purified mRNA from MDA-MB-231 cells. At the top is a figure that represents the complete Sp3 cDNA; the solid line represents the previously published sequence, and the dotted line represents the unknown sequence. The smaller horizontal lines that are located underneath this line represent a clone that was sequenced and aligned with a known Sp3 sequence as well as other clones. A previously known sequence is on the right (underneath the solid line), while new sequence data that were obtained from the clones are on the left (underneath the dotted line). The primer for first-strand synthesis is listed first, followed by the primer used for the nested PCR. A third primer is listed in cases when a second nested PCR was performed. The number above the line represents the number of basepairs of the new sequence that each clone contained. (B) Analysis of the sequence that was obtained by 5'RACE showed that termination codons were present in all three reading frames. However, no AUG initiation codon was found. Since the known open-reading frame was located 3' to the sequence that was obtained by 5'RACE, a non-AUG initiation codon was probably present. #AY070137). A sequence analysis revealed that there were no in-frame AUG codons in the 5' sequence of the known coding region. Also, at least one stop codon was present in each of the three reading frames 5' to the known coding region (Fig.  2B) . To verify that these data were accurate (not the result of a PCR error, nor a finding that was restricted to the MDA-MB-231 cell line), RT-PCR was performed over a region that contained the 5' end of the previously published sequence and the region containing all of the stop codons in the nine human cell lines. They were as follows: MDA-MB-231, MCF7 (mammary gland adenocarcinoma), SW-13 (adrenal gland small cell carcinoma), TSU-pr1 (prostate carcinoma), ME-180, (cervical epidermoid carcinoma), and 4 EBV transformed human B-cell lines from different donors. The amplified fragments were subcloned and sequenced. Sequencing data confirmed that there were no basepair errors in the 5' region that contained the 5' stop codons through the known translated sequence (data not shown).
Northern blot analysis using a radiolabeled probe that is specific for the newly obtained 5' sequence detected 1 band that migrated at 4 kb (Fig. 3) . It is the same size as the species that was detected by a probe specific for the published sequence of Sp3 (Fig. 1) . Although apparently the bands are slightly different in size between cell lines, they consistently run at the bottom edge of the 28S band in all of the screened cell lines.
Testing the new sequence To obtain a full expression construct for Sp3, 3'RACE was performed using the Marathon Ready cDNA Kit from Clontech. The 3' Sp3 clone that amplified with the Sp3-3R3 primer in leukocytes was ligated to the 5' sequence to obtain a full expression clone. This expression clone was translated in a transcription and translation coupled rabbit reticulocyte lysate system in the presence of [ 35 S]-methionine (Fig. 4) . The expected three isoforms of Sp3 were produced (one at 100 kDa and two in the mid-60 kDa range). The smaller isoforms are produced from two internal AUG sites that are located at bps 1036-1038, and bps 1087-1089 (Kennett et al., 1997) . This experiment was repeated in wheat germ extract, and the same results were obtained (data not shown). Since no in-frame AUG codon is present 5' to these internal start codons, by default, the larger 100 kDa isoform must be initiated at a non-AUG translation initiation site.
To assess whether these translated proteins were functional, the expression clone was translated in vitro without a radioactive label and used in an electrophoretic mobility shift assay (Fig. 5) . Lane 1 shows non-specific binding of the labeled oligo to proteins in the rabbit reticulocyte lysates. As is seen in lane 2, three new bands are present when in vitro translated Sp3 from our clone is added. These complexes cannot be competed off with non-specific DNA (lane 3), but can be reduced in the presence of an unlabeled GC box consensus sequence (lane 4). Finally, the anti-Sp3 antibody was able to abolish the formation of all three complexes completely. These data show that all three synthesized proteins recognize and bind the Sp3 consensus sequence, and are recognized by an antibody that is specific for Sp3.
Identifying the translation initiation site
To identify the start site, several gain-of-function site-specific mutations were introduced into the Sp3 expression construct. These gain-offunction mutations replaced the non-AUG codons with AUG codons. Since previous studies showed that non-AUG translation initiation sites tend to be in strong context and differ from AUG by only one nucleotide (reviewed in Hann, 1994) , the sites for mutagenesis were chosen based on the Kozak consensus sequence (Kozak, 1987) and whether or not the codon had only a one basepair difference from AUG (Fig.  6A) . The only two codons to meet both of these criteria were AUA 385-387 and UUG [469] [470] [471] . The 5' mutation (CUG 364-366 ) was investigated (though only in a moderate context), because CUG has been described as an initiation codon in several instances (reviewed in Hann 1994). The AUcG 396-399 deletion mutation was chosen in case a ribosomal frameshift type mechanism might have been responsible for recognizing an "AUG" in a moderate context, and shifting the translated product into the open-reading frame. Finally, the GCC 454-456 codon was investigated since it was surrounded by the ideal Kozak consensus sequence. These non-AUG to AUG mutation constructs and wild-type sequence were translated into rabbit reticulocyte lysates in vitro and analyzed by SDS-PAGE (Fig. 6B) . The AUA 385-387 to AUG and AUcG 396-399 to AUG mutants ran most closely to the wild-type. The CUG 364-366 band ran slightly higher than the wt Sp3. As was expected, the gain-of-function mutations were all more efficient in initiating translation than was the wild-type construct, because AUG initiation codons are more efficient than non-AUG initiation codons (Hann, 1994) . In lane 6, the wild-type sequence can be seen migrating above the UUG 469-471 to AUG mutation product, signifying that the wildtype start codon is located 5' to codon UUG [469] [470] [471] . A further analysis by SDS-PAGE determined that the AUA 385-387 to AUG mutant migrated in a manner that has more of a similarity to the wild-type than did the AUcG 396-399 to AUG mutant construct (data not shown).
Non-AUG to AUG mutations were introduced, replacing the AUA 385-387 codon or the adjacent codon AAG 382-384 or GGG [388] [389] [390] . The products of all three constructs migrate at approximately the level of the wild-type construct (Fig. 7) . The one amino acid difference between the products of the AUA [385] [386] [387] to AUG (lane 3), the AAG 382-384 to AUG (lane 1), and GGG [388] [389] [390] to AUG (lane 5) constructs cannot be clearly detected using full-length constructs.
To aid in the identification of the translation initiation site, additional nucleotides were introduced into the wild-type sequence to create change-of-frame mutations (Fig. 8) . If the nucleotides are introduced into the translated portion of the sequence, they should cause a nonsense mutation, resulting in a truncated translation product and the loss of the large isoform of Sp3. However, if the inserted nucleotide is present in the 5' untranslated region, the larger isoform should still be translated. As can be seen in lane 2, an insertion immediately 5' to the AUA codon does not result in the loss of the large Sp3 isoform. On the other hand, an insertion 3' to the AUA codon (lanes 4 and 5), or an insertion that destroys the AUA codon (lane 3), results in the loss of the large isoform. This is consistent with AUA that serves as the translation initiation site. All of the introduced mutations maintain (lanes 2-4) or enhance (lane 5) the context of the in-frame codon immediately downstream of the insertion, making it unlikely that the loss of the larger isoform was due to context effects. The reduced intensity of the larger isoform in lane 2 may indicate that a G in the -3 position of a non-AUG initiation codon does not contribute as strongly to the context as an A. Another possibility is that the mutation changes the secondary structure of the region, making translation initiation at the AUA less efficient since secondary structure influences the translation of non-AUG initiation codons (Kozak 1990 ).
To further investigate the possible role of the AUA 385-387 codon as a translation initiation site, several loss-of-function mutations were generated (Fig. 9) . As can be seen in lanes 7-12, mutations that converted the AUA 385-387 codon from strong to moderate (AUA-3U, AUA+4U), or the weak (AUA-3U +4U) context, resulted in the loss of the larger isoform. Furthermore, the larger isoform was also lost when the AUA 385-387 codon was replaced with a codon that differed from AUG by more than one nucleotide (CAG) (lanes 13 and 14) . In lanes 3 and 4, no effect was seen on the production of the larger isoform when a mutation was made that changed the context of the AAG 382-384 codon from moderate to weak (AAG -3U). In addition, in lanes 5 and 6, a mutation was tested that served as a gain-of-function mutation for the AAG 382-384 codon by changing its context from moderate to strong. This mutation was also a loss-of-function mutation for the AUA 385-387 codon. With respect to the GGG 388-390 codon, the AAG+4G mutation should have maintained a moderate context. This AAG+4G mutation resulted in the loss of the larger isoform (lanes 5 and 6). This is consistent with AUA 385-387 , and not AAG [382] [383] [384] being the initiation codon. Furthermore, the AUA -3U mutation should not have influenced the context of the GGG [388] [389] [390] codon, yet it resulted in a loss of the larger isoform. It should be noted that GGG has never been described as an initiation codon. It differs from AUG by more than one nucleotide, and is only in moderate context. Therefore, it does not meet any of the criteria of a non-AUG initiation codon. The decrease in intensity of the two smaller isoforms in the AUA+4U mutation (lanes 9 and 10) may be due to a disruption in the secondary structure of a possible internal ribosome entry site since the production of the two smaller isoforms is cap-independent (data not shown).
To detect a one-amino acid difference, the smaller, truncated expression products were generated by introducing a stop codon 207 amino acids after the AUA 385-387 codon, 5' to the two internal start sites. The premature stop codon was introduced into the wild-type Sp3 sequence, the AUA 385-387 to AUG construct, and the AAG 382-384 to AUG construct (Fig. 10) . The truncated protein that was produced from the wild-type stop 207 construct, and the product from the AUA 385-387 stop 207 construct, migrated to the same extent. On the other hand, the AAG 382-384 stop 207 construct migrated at a larger size. This is consistent with the AUA 385-387 codon serving as the translation initiation site.
Discussion
We have shown that, in vitro, AUA 385-387 can serve as the translation initiation site for the larger isoform of Sp3 using the transcript that is derived from Fig. 2 (AUA transcript) . Furthermore, the large isoform of Sp3 initiates translation with methionine (Fig. 10) since the only radiolabel present is methionine, and no internal methionines are present in the coding region for the wt stop 207 construct. Although AUA has not been previously described as an endogenously Mutations from wild-type are given in bold and underlined. The codon, whose context is affected, is given in italics and underlined. Fig. 10 . Introduction of a premature stop codon into the coding sequence for Sp3. A mutation creating a stop codon 207 amino acids into the open-reading frame was introduced in non-AUG to AUG mutation and wild-type constructs. These dual mutation constructs were expressed in vitro in the T N T coupled rabbit reticulocyte lysate kit with [ 35 S]methionine, and analyzed by 9% SDS-PAGE. The designations under the lanes represent the non-AUG codon, which was mutated into an AUG codon for the construct that is expressed in that lane. Underneath the gel is listed the wild-type (wt) Sp3 sequence over the region where the mutations are located. At the bottom of the figure is a diagram that shows where the stop codon was introduced, compared to the AUA codon and the internal initiation sites.
occurring translation initiation site in eukaryotes, previous studies have shown that AUA can be utilized as a translation initiation site in eukaryotes when experimentally introduced and presented in an appropriate context (Peabody, 1989; Mehdi et al., 1990) , albeit inefficiently. Furthermore, AUA has been reported to have the ability to bind met i -tRNA (Kellogg et al., 1966) .
Northern blot data verify that full-length cDNA (3979 nt sequenced cDNA, and 4 kb by northern blot) was used, and that the obtained 5' sequence data were not due to intronic artifact (the co-localization of the IP F 17-IP R 18 and the H8-F3 probes). The possibility that these data were obtained from unspliced RNA was highly unlikely in any event, because all of the 5'RACE reactions were performed with poly-A isolated RNA. Furthermore, RT-PCR verification of the sequence was done with primers which amplified products that spanned exon-intron junctions as identified on the genomic clone for Sp3 (accession #AC016737). Even if a small portion of the 5' end of the RNA was not obtained by 5'RACE, no 5' initiation sites could be present since translation termination codons are present in all three reading frames between the obtained 5' end of the mRNA and the known open-reading frame for Sp3.
Genes with non-AUG translation initiation sites have several common characteristics (reviewed in Hann, 1994) . Most genes with non-AUG initiation sites tend to have large 5' untranslated regions (most other genes have 5'UTRs less than 300 bps). They are also usually located in GC rich regions, most likely due to a favorable secondary structure. Non-AUG initiation sites are usually in optimal context (CCG/ACCXXXG), or have a favorable secondary structure that surrounds them, such as a hairpin loop located 14-16 bps downstream. Genes that have non-AUG initiation sites tend to be transcription factors, tyrosine kinases, and growth factors. Finally, non-AUG initiation codons usually are less efficient (5-30%) than AUG codons, as measured by the total protein product that was synthesized. Sp3, a transcription factor, fits nicely into this model. Sp3 has almost 400 bps 5' to the AUA, which is in strong context. The 5' end of Sp3 is over 70% GC rich, while the region immediately surrounding the AUA codon is 80% GC rich. Finally, as can be seen by in vitro translation, the non-AUG start codon is less efficient than when it is replaced with AUG.
A non-AUG initiation codon may be used for several reasons. First, due to their inefficiency and the classes of genes on which they have been located, non-AUG initiation codons may be used to restrict the synthesis of potent proteins. For example, overexpression of growth factors can lead to tumorigenesis. Secondly, non-AUG initiation sites may allow new forms of translational regulation. For example, in the case of c-myc, which has an AUG initiated (growth stimulatory) and a non-AUG initiated (growth inhibitory) isoform (Hann, 1994) , the non-AUG isoform is translated more efficiently than the AUG isoform when cells are amino acid starved. Since non-AUG codon initiated proteins are usually synthesized simultaneously with AUG initiated forms that are located downstream, non-AUG sites permit the synthesis of overlapping proteins with different N-termini. This allows the proteins to be synthesized with either different functions or to be targeted to different parts of the cell.
Future studies should be performed to test the new Sp3 construct in vivo to verify the production of all three isoforms. These assays will be valuable in testing to see how efficient the AUA site is in vivo. These assays can also be used to determine if cells can regulate the ratio of the three isoforms under certain conditions, such as amino acid deprivation. Finally, it is important to ascertain whether the activity of this new construct is consistent with, or is significantly different from, previous studies using Sp3.
The regulation of Sp3 activity is complex, and most likely occurs on numerous levels. For example, we have shown that the lack of Sp3 transcription in peripheral blood mononuclear cells has been associated with multiple sclerosis (Grekova et al., 1996) . Sp3 function may also be controlled by the ratio of Sp3 isoforms (Kennett et al., 1997) , which can be determined at a transcriptional or translational level, or by the presence of an inhibitory factor (Suske, 1999) . In addition, Sp3 competes with Sp1 for the same GC box binding motif (Hagen et al., 1992) , creating a dynamic relationship that results in gene activation or repression. The presence of a non-AUG translation initiation site can potentially allow the translational regulation of the larger isoform that is independent of global, AUG initiated translation and the initiation of the smaller isoforms; therefore, it has implications in the regulation of Sp3 and its activity. Furthermore, the identification of AUA as a non-AUG translation initiation site has importance in understanding translation initiation and the identification of possible alternative translation products in eukaryotic genes.
